Vildagliptin Cyclo Imidamide

• CAT Number: R075012
• CAS Number: 1789703-37-2
• Molecular Formula: C₁₇H₂₅N₃O₂
• Molecular Weight: 303.4
• Purity: ≥95%
• Synonyms: Vildagliptin Impurity E; 2-((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-one
• Appearance: Pale Yellow to Yellow Solid
• IUPAC Name: 2-(3-hydroxy-1-adamantyl)-1-imino-6,7,8,8a-tetrahydro-3H-pyrrolo[1,2-a]pyrazin-4-one
• InChI: InChI=1S/C17H25N3O2/c18-15-13-2-1-3-19(13)14(21)9-20(15)16-5-11-4-12(6-16)8-17(22,7-11)10-16/h11-13,18,22H,1-10H2
• InChIKey: ZZYCWDSBZNHPIN-UHFFFAOYSA-N
• SMILES: C1CC2C(=N)N(CC(=O)N2C1)C34CC5CC(C3)CC(C5)(C4)O

Vildagliptin Cyclo Imidamide (also known as LAF237 Cyclo Imidamide)(CAT: R075012) is a derivative of Vildagliptin, which is an oral anti-diabetic drug used for the treatment of type 2 diabetes. Vildagliptin Cyclo Imidamide is being developed as a potential treatment for type 2 diabetes and is currently in the preclinical stage of development.